PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Gesamtlänge aller Episoden: 9 days 5 hours 15 minutes
From Bench to Bedside: Updates in the Management of Haematologic Malignancies
From Bench to Bedside: Updates in the Management of Haematologic Malignancies
Moving Forward in Ulcerative Colitis Treatment: Incorporating New Options Into Canadian Practice
Go online to www.peervoice.com/h/pvr162 to view the entire programme with slides.
Lessons From Real-World Experience in Multiple Sclerosis
Lessons From Real-World Experience in Multiple Sclerosis
Journal Club: Impact of Inhaled Corticosteroid Withdrawal on COPD Exacerbations
Journal Club: Impact of Inhaled Corticosteroid Withdrawal on COPD Exacerbations
Management of Patients With Untreated AML Ineligible for Intensive Remission Induction Therapy: Challenges and Opportunities
Go online to www.peervoice.com/h/pve52 to view the entire programme with slides.
Hedgehog Pathway Inhibitors for the Treatment of Advanced Basal Cell Carcinoma: Towards a Patient-Centred Approach
Go online to www.peervoice.com/h/pvr164 to view the entire programme with slides.
Current and Emerging Approaches to Viral Cure in Chronic Hepatitis B and HIV
Current and Emerging Approaches to Viral Cure in Chronic Hepatitis B and HIV
An In-Depth Look at the EMA Guidelines for Biosimilars From Creation to Care
An In-Depth Look at the EMA Guidelines for Biosimilars From Creation to Care
Biologic Treatment Decisions in RA: Considering Mechanisms, Evidence, and Patients
Go online to www.peervoice.com/h/pvr157 to view the entire programme with slides.
Why is There a Window of Opportunity? The Immunopathological Basis of MS
Why is There a Window of Opportunity? The Immunopathological Basis of MS